Skip to main content
OpenTrials

Clinical trial condition

Peritoneal Neoplasms

Explore clinical trials studying Peritoneal Neoplasms. Study availability and eligibility vary by location and protocol.

56 public trials 5 recruiting studies
Refine in advanced search Browse all conditions

Peritoneal Neoplasms trial results

Active, not recruiting

PARP-inhibition and CTLA-4 Blockade in BRCA-deficient Ovarian Cancer

NCT02571725

Conditions
Abdominal Neoplasms, Adnexal Diseases, Digestive System Diseases, +21 more
Locations
  • Moffitt Cancer Center Tampa, Florida, United States
  • Southwest Gynecologic Oncology Associates Albuquerque, New Mexico, United States
  • University of New Mexico Comprehensive Cancer Center Albuquerque, New Mexico, United States
  • The Ohio State University Columbus, Ohio, United States
View Trial Details
Active, not recruiting

Relacorilant in Combination With Nab-Paclitaxel in Advanced, Platinum-Resistant, High-Grade Epithelial Ovarian, Primary Peritoneal, or Fallopian-Tube Cancer

NCT05257408

Conditions
Abdominal Neoplasms, Adnexal Diseases, Digestive System Diseases, +20 more
Locations
  • Site 318 Phoenix, Arizona, United States
  • Site 277 Tucson, Arizona, United States
  • Site 350 Irvine, California, United States
  • Site 364 La Jolla, California, United States
View all 117 locations
View Trial Details
Completed

Predictors of Relapse of Ovarian, Peritoneal, and Fallopian Tube Cancers

NCT00086567

Conditions
Abdominal Neoplasms, Adnexal Diseases, Carcinoma, +25 more
Locations
  • University of Alabama at Birmingham Birmingham, Alabama, United States
  • Cedars Sinai Medical Center Los Angeles, California, United States
  • Evanston Northwestern University Hospital Evanston, Illinois, United States
  • National Institutes of Health Clinical Center Bethesda, Maryland, United States
View Trial Details
Completed

Study of Chemotherapy With Pembrolizumab (MK-3475) Followed by Maintenance With Olaparib (MK-7339) for the First-Line Treatment of Women With BRCA Non-mutated Advanced Epithelial Ovarian Cancer (EOC) (MK-7339-001/KEYLYNK-001/ENGOT-ov43/GOG-3036)

NCT03740165

Conditions
Abdominal Neoplasms, Adnexal Diseases, Digestive System Diseases, +22 more
Locations
  • University of Alabama at Birmingham (UAB) ( Site 0036) Birmingham, Alabama, United States
  • University of Arizona Cancer Center ( Site 0074) Tucson, Arizona, United States
  • Disney Family Cancer Center ( Site 0042) Burbank, California, United States
  • Kaiser Permanente Oncology Clinical Trial -Oakland ( Site 0077) Oakland, California, United States
View all 227 locations
View Trial Details
Completed

An Interventional Study of Avastin (Bevacizumab) in Patients With Advanced/Metastatic Epithelial Ovarian Cancer, Fallopian Tube Cancer or Primary Peritoneal Cancer

NCT01932125

Conditions
Abdominal Neoplasms, Adnexal Diseases, Digestive System Diseases, +19 more
Locations
  • Manipal Hospital Bangalore, Karnataka, India
  • HealthCare Global Enterprises Limited Banglore, Karnataka, India
  • Marthwada Regional Cancer Center & Research Institute Aurangabad, Maharashtra, India
  • MOC Cancer Care & Research Centre Mumbai, Maharashtra, India
View all 13 locations
View Trial Details
Completed

Phase I Study of Cantrixil in Patients With Ovarian Cancer, Fallopian Tube Cancer or Primary Peritoneal Cancer.

NCT02903771

Conditions
Abdominal Neoplasms, Adnexal Diseases, Digestive System Diseases, +19 more
Locations
  • Peggy and Charles Stephenson Cancer Center, OU Health Sciences Center Oklahoma City, Oklahoma, United States
  • Lifespan Cancer Institute, Rhode Island Hospital Providence, Rhode Island, United States
  • Mary Crowley Cancer Research Center Dallas, Texas, United States
  • Westmead Adults Hospital Westmead, New South Wales, Australia
View Trial Details
Completed

A Study of Atezolizumab Versus Placebo in Combination With Paclitaxel, Carboplatin, and Bevacizumab in Participants With Newly-Diagnosed Stage III or Stage IV Ovarian, Fallopian Tube, or Primary Peritoneal Cancer

NCT03038100

Conditions
Abdominal Neoplasms, Adnexal Diseases, Digestive System Diseases, +21 more
Locations
  • St. Joseph'S Hospital & Medical Center Phoenix, Arizona, United States
  • Arizona Oncology Associates, PC - HAL Scottsdale, Arizona, United States
  • Arizona Oncology - HOPE Wilmot Tucson, Arizona, United States
  • Moores Cancer Center at UC San Diego Health La Jolla, California, United States
View all 268 locations
View Trial Details

Related conditions